Quick Takeaways
- This page summarizes Jon Snodgres's Form 4 filing for REPLIGEN CORP (RGEN).
- 6 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 17 Aug 2022, 16:41.
Jon Snodgres - 16 Aug 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)
- Signature
- /s/ Kimberly Brown (Attorney in Fact)
- Issuer symbol
- RGEN
- Transactions as of
- 16 Aug 2022
- Net transactions value
- -$1,222,229
- Form type
- 4
- Filing time
- 17 Aug 2022, 16:41:45 UTC
- Previous filing
- 02 Aug 2022
- Next filing
- 11 Oct 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Jon Snodgres filed Form 4 for REPLIGEN CORP (RGEN) on 17 Aug 2022."
What Changed
- Previous filing in this sequence was filed on 02 Aug 2022.
- Current net transaction value: -$1,222,229.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Common Stock | Options Exercise | $262,347 | +3,047 | +8.2% | $86.10 | 40,234 | 16 Aug 2022 | Direct | |
| transaction | RGEN | Common Stock | Options Exercise | $209,113 | +970 | +2.4% | $215.58 | 41,204 | 16 Aug 2022 | Direct | |
| transaction | RGEN | Common Stock | Sale | $1,086,105 | -4,298 | -10% | $252.70 | 36,906 | 16 Aug 2022 | Direct | F1 |
| transaction | RGEN | Common Stock | Sale | $607,584 | -2,400 | -6.5% | $253.16 | 34,506 | 16 Aug 2022 | Direct |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGEN | Stock Option (Right to Buy) | Options Exercise | $0 | +3,047 | $0.000000 | 1,524 | 16 Aug 2022 | Common Stock | 3,047 | $86.10 | Direct | F2 | |
| transaction | RGEN | Stock Option (Right to Buy) | Options Exercise | $0 | +970 | +100% | $0.000000 | 1,940 | 16 Aug 2022 | Common Stock | 970 | $215.58 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F2 | 1,524 shares vest and become exercisable on 2/27/2023. |
| F3 | Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024. |